2019
DOI: 10.1053/j.jvca.2019.02.013
|View full text |Cite
|
Sign up to set email alerts
|

The Coagulopathy of Acute Type A Aortic Dissection: A Prospective, Observational Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
33
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(37 citation statements)
references
References 23 publications
4
33
0
Order By: Relevance
“…Ehlers-Danlos syndrome has been reported in 0.6% of patients with ATAAD in the GERAADA registry [40]. It includes various genetic defects affecting the biosynthesis or structure of collagen type I, II, and V. Among the six major different Ehlers-Danlos subtypes, the vascular subtypetogether with the vascular-like subtype-are of special interest in the context of aortic disease as these impact Procollagen type III and Procollagen type I, respectively.…”
Section: Risk Factorsmentioning
confidence: 99%
“…Ehlers-Danlos syndrome has been reported in 0.6% of patients with ATAAD in the GERAADA registry [40]. It includes various genetic defects affecting the biosynthesis or structure of collagen type I, II, and V. Among the six major different Ehlers-Danlos subtypes, the vascular subtypetogether with the vascular-like subtype-are of special interest in the context of aortic disease as these impact Procollagen type III and Procollagen type I, respectively.…”
Section: Risk Factorsmentioning
confidence: 99%
“…The repair of a dissected aorta involves significant intraoperative blood loss and associated coagulopathy. 46 The authors' hemostasis management was guided by thromboelastometry and included multiple allogeneic component therapy and intraoperative AWB collection. Use of AWB after ticagrelor ingestion remains controversial owing to the concern of reinfusing ticagrelor into the circulation.…”
Section: Discussionmentioning
confidence: 99%
“…Use of procoagulant factor concentrates, such as recombinant activated factor VII (rFVIIa), and activated or nonactivated prothrombin complex concentrate (APCC and PCC, respectively) has been reported as adjunct hemostatic agents after CPB. 46,[50][51][52] None of these agents directly improves platelet P2Y 12 function, but these agents potentially can improve platelet aggregability via protease (thrombin)-activated receptors (PAR-1 and PAR-4) signaling. A combined abnormality in P2Y 12 and PAR responses appears to increase the risk of severe bleeding after cardiac surgery.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients with acute type A aortic dissection are commonly found to have coagulation disorder preoperatively, such as by low PLT and fibrinogen and high D-dimer and PT-INR [ 9 ]. However, it is impractical to conduct advanced coagulation tests in all cases prior to emergency surgery, because FXII deficiency is extremely infrequent (1 in 1 million individuals) [ 10 ].…”
Section: Discussionmentioning
confidence: 99%